Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition By: Benzinga via Benzinga July 29, 2014 at 11:49 AM EDT In a note released Tuesday, Citi analysts noted that AstraZeneca (NYSE: AZN) is still the most attractive acquisition target for ... Read More >> Related Stocks: Astrazeneca Plc ADR Pfizer